We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Janssen-Cilag Ltd

50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG, UK
Telephone: +44 1494 567 567
Fax: +44 1494 567 568
Medical Information Direct Line: +353 1 800 709 122
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +353 1 620 2300
Medical Information Facsimile: +44 (0) 1494 567 445
Patient Information Leaflet last updated on medicines.ie: 17/03/2017
PIL CONCERTA XL 18 mg and 36 mg prolonged-release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 17/03/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 17/05/2016 and displayed until 17/03/2017
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 17/07/2015 and displayed until 17/05/2016
Reasons for adding or updating:
  • Change to date of revision
  • Addition of information on reporting a side effect.
Updated on 02/09/2014 and displayed until 17/07/2015
Reasons for adding or updating:
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 28/11/2012 and displayed until 02/09/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 16/08/2011 and displayed until 28/11/2012
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 24/06/2011 and displayed until 16/08/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to side-effects
  • Change to date of revision
Updated on 01/11/2010 and displayed until 24/06/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/02/2010 and displayed until 01/11/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 12/02/2009 and displayed until 08/02/2010
Reasons for adding or updating:
  • PIL re-instated
Updated on 28/08/2008 and displayed until 12/02/2009
Reasons for adding or updating:
  • Addition of marketing authorisation holder
Updated on 17/10/2007 and displayed until 28/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 03/09/2007 and displayed until 17/10/2007
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
  • Change due to user-testing of patient information
Updated on 16/01/2007 and displayed until 03/09/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
Updated on 19/05/2005 and displayed until 16/01/2007
Reasons for adding or updating:
  • Change to storage instructions
  • Change to warnings or special precautions for use
Updated on 16/11/2004 and displayed until 19/05/2005
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Methylphenidate Hydrochloride